|
VTGN Vistagen Therapeutics Inc 1411685 |
| Balance Sheet |
|
Current Assets
|
99,948,000 |
|
Assets
|
102,496,000 |
|
Current Liabilities
|
7,523,000 |
|
Liabilities
|
9,522,000 |
|
Equity
|
92,974,000 |
|
Shares Out
|
27,055,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-21,755,000 |
|
Investing Cash Flow
|
-13,253,000 |
| Market Analysis |
Market Cap
|
83,735,535 |
|
BVPS
|
3.44 |
|
PB
|
0.85 |
|
EPS
|
-1.53 |
|
PS
|
114.39 |
|
FCF
|
-35,008,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view VTGN documents filed with the SEC.
VTGN Filings
Clear
